Is ELMT a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Federal capital and a stockpile offtake, at the same time, with revenue (ttm) at ~$229M, up ~20% year over year. The bear case rests on dilution is the first thing to size: the government warrants cover up to 19.9% of the common stock on a post-transaction basis, and the IPO lockup on the April offering runs about 180 days from the April 23 debut, which places it in late October 2026. Analysts covering it are spread from $20.00 to $26.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Dilution is the first thing to size: the government warrants cover up to 19.9% of the common stock on a post-transaction basis, and the IPO lockup on the April offering runs about 180 days from the April 23 debut, which places it in late October 2026. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $20.00, -7.0% from the $21.50 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Federal capital and a stockpile offtake, at the same time. The September 14 package pairs money with demand. The most optimistic analyst target on ELMT is $26.00, +20.9% from the $21.50 price. That figure is only reachable if this thesis works close to its best case.

Dilution is the first thing to size: the government warrants cover up to 19.9% of the common stock on a post-transaction basis, and the IPO lockup on the April offering runs about 180 days from the April 23 debut, which places it in late October 2026. Only 8.6 million of roughly 30.5 million shares were sold in the IPO, so the float is thin and the price moves hard on news in both directions. Execution risk is a genuine step change rather than an extension: restarting a Nevada mine in late 2027 and an APT conversion plant in 2028 is a different business from machining refractory parts, and the schedule is years out. Reported growth flatters the underlying volume, since roughly 45% of Q2's increase came from raw material price pass-through, which reverses if tungsten prices fall back. The company also posted a GAAP net loss of ~$4.5 million in Q2 on ~$14.2 million of equity compensation, carries real customer concentration (medical backlog fell from ~$12 million to ~$5.5 million on one large customer's ordering pattern), and after the September rally trades above the ~$20.75 average target of the four analysts covering it. The most pessimistic published target is $20.00, -7.0% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

The Elmet Group is a 97-year-old Maine fabricator of tungsten and molybdenum components for defense, semiconductor and medical customers, plus RF and microwave systems.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Federal capital and a stockpile offtake, at the same time) stalling in the reported numbers rather than in the narrative, the risk above (dilution is the first thing to size: the government warrants cover up to 19.9% of the common stock on a post-transaction basis, and the IPO lockup on the April offering runs about 180 days from the April 23 debut, which places it in late October 2026) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

ELMT lists on the Nasdaq Capital Market, so any US brokerage that offers listed equities can execute the order. Because the float is small (about 8.6 million of roughly 30.5 million shares came out in the April 2026 IPO) and the stock has moved more than 30% in a single session, limit orders behave more predictably than market orders here.

It was a conventional underwritten IPO, not a de-SPAC. Elmet priced 8.6 million shares at $14.00 on April 22, 2026, the top of a $12 to $14 range, and shares opened at $18.00 the next day. Net proceeds were roughly $125.5 million, about $17.8 million of term debt was retired, and the business itself dates to 1929.

Two things. The Critical Materials Components division machines tungsten, molybdenum, niobium and tantalum into precision parts for defense, aerospace, medical imaging, semiconductor tooling and energy customers. The Engineered Microwave Products division builds custom high-power microwave and RF energy systems for industrial and research use. CMC is the larger division and drives most of the profit.